1,763
Views
13
CrossRef citations to date
0
Altmetric
Research Paper

O-specific polysaccharide confers lysozyme resistance to extraintestinal pathogenic Escherichia coli

, , , , , & show all
Pages 666-680 | Received 11 Jul 2017, Accepted 18 Jan 2018, Published online: 19 Mar 2018

References

  • Mason DY, Taylor CR. The distribution of muramidase (lysozyme) in human tissues. J Clin Pathol. 1975;28:124–32. doi:10.1136/jcp.28.2.124
  • Yang CT, Cambier CJ, Davis JM, et al. Neutrophils exert protection in the early tuberculous granuloma by oxidative killing of mycobacteria phagocytosed from infected macrophages. Cell Host Microbe. 2012;12:301–12. doi:10.1016/j.chom.2012.07.009
  • Callewaert L, Michiels CW. Lysozymes in the animal kingdom. J Biosci. 2010;35:127–60. doi:10.1007/s12038-010-0015-5
  • Laible NJ, Germaine GR. Bactericidal activity of human lysozyme, muramidase-inactive lysozyme, and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: inhibition by chitin oligosaccharides. Infect Immun. 1985;48:720–8.
  • Derde M, Guerin-Dubiard C, Lechevalier V, et al. Dry-heating of lysozyme increases its activity against Escherichia coli membranes. J Agric Food Chem. 2014;62:1692–700. doi:10.1021/jf405155p
  • Derde M, Nau F, Lechevalier V, et al. Native lysozyme and dry-heated lysozyme interactions with membrane lipid monolayers: lateral reorganization of LPS monolayer, model of the Escherichia coli outer membrane. Biochim Biophys Acta. 2015;1848:174–83. doi:10.1016/j.bbamem.2014.10.026
  • During K, Porsch P, Mahn A, et al. The non-enzymatic microbicidal activity of lysozymes. FEBS Lett. 1999;449:93–100. doi:10.1016/S0014-5793(99)00405-6
  • Nash JA, Ballard TN, Weaver TE, et al. The peptidoglycan-degrading property of lysozyme is not required for bactericidal activity in vivo. J Immunol. 2006;177:519–26. doi:10.4049/jimmunol.177.1.519
  • Davis KM, Weiser JN. Modifications to the peptidoglycan backbone help bacteria to establish infection. Infect Immun. 2011;79:562–70. doi:10.1128/IAI.00651-10
  • Callewaert L, Van Herreweghe JM, Vanderkelen L, et al. Guards of the great wall: bacterial lysozyme inhibitors. Trends Microbiol. 2012;20:501–10. doi:10.1016/j.tim.2012.06.005
  • Bera A, Biswas R, Herbert S, et al. Influence of wall teichoic acid on lysozyme resistance in Staphylococcus aureus. J Bacteriol. 2007;189:280–3. doi:10.1128/JB.01221-06
  • Bera A, Herbert S, Jakob A, et al. Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus. Mol Microbiol. 2005;55:778–87. doi:10.1111/j.1365-2958.2004.04446.x
  • Monchois V, Abergel C, Sturgis J, et al. Escherichia coli ykfE ORFan gene encodes a potent inhibitor of C-type lysozyme. J Biol Chem. 2001;276:18437–41. doi:10.1074/jbc.M010297200
  • Callewaert L, Aertsen A, Deckers D, et al. A new family of lysozyme inhibitors contributing to lysozyme tolerance in gram-negative bacteria. PLoS Pathog. 2008;4:e1000019. doi:10.1371/journal.ppat.1000019
  • Vanderkelen L, Van Herreweghe JM, Vanoirbeek KG, et al. Identification of a bacterial inhibitor against g-type lysozyme. Cell Mol Life Sci. 2011;68:1053–64. doi:10.1007/s00018-010-0507-3
  • Van Herreweghe JM, Vanderkelen L, Callewaert L, et al. Lysozyme inhibitor conferring bacterial tolerance to invertebrate type lysozyme. Cell Mol Life Sci. 2010;67:1177–88. doi:10.1007/s00018-009-0241-x
  • Li M, Le Trong I, Carl MA, et al. Structural basis for type VI secretion effector recognition by a cognate immunity protein. PLoS Pathog. 2012;8:e1002613. doi:10.1371/journal.ppat.1002613
  • Ohno N, Morrison DC. Lipopolysaccharide interaction with lysozyme. Binding of lipopolysaccharide to lysozyme and inhibition of lysozyme enzymatic activity. J Biol Chem. 1989;264:4434–41.
  • Moriel DG, Bertoldi I, Spagnuolo A, et al. Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli. PNAS. 2010;107:9072–7. doi:10.1073/pnas.0915077107
  • Garcia-Gonzalez L, Geeraerd AH, Mast J, et al. Membrane permeabilization and cellular death of Escherichia coli, Listeria monocytogenes and Saccharomyces cerevisiae as induced by high pressure carbon dioxide treatment. Food Microbiol. 2010;27:541–9. doi:10.1016/j.fm.2009.12.004
  • Moyo B, Mukanganyama S. Antibacterial Effects of Cissus welwitschii and Triumfetta welwitschii Extracts against Escherichia coli and Bacillus cereus. Int J Bacteriol. 2015;2015:162028.
  • Miki T, Holst O, Hardt WD. The bactericidal activity of the C-type lectin RegIIIbeta against Gram-negative bacteria involves binding to lipid A. J Biol Chem. 2012;287:34844–55. doi:10.1074/jbc.M112.399998
  • Ma J, Sun M, Bao Y, et al. Genetic diversity and features analysis of type VI secretion systems loci in avian pathogenic Escherichia coli by wide genomic scanning. Infect Genet Evol. 2013;20:454–64. doi:10.1016/j.meegid.2013.09.031
  • Brandenburg K, Koch MH, Seydel U. Biophysical characterisation of lysozyme binding to LPS Re and lipid A. Eur J Biochem. 1998;258:686–95. doi:10.1046/j.1432-1327.1998.2580686.x
  • Santos NC, Silva AC, Castanho MA, et al. Evaluation of lipopolysaccharide aggregation by light scattering spectroscopy. Chembiochem. 2003;4:96–100. doi:10.1002/cbic.200390020
  • Masschalck B, Michiels CW. Antimicrobial properties of lysozyme in relation to foodborne vegetative bacteria. Crit Rev Microbiol. 2003;29:191–214. doi:10.1080/713610448
  • Romanini D, Braia M, Angarten RG, et al. Interaction of lysozyme with negatively charged flexible chain polymers. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;857:25–31. doi:10.1016/j.jchromb.2007.06.025
  • Derde M, Lechevalier V, Guerin-Dubiard C, et al. Hen egg white lysozyme permeabilizes Escherichia coli outer and inner membranes. J Agric Food Chem. 2013;61:9922–9. doi:10.1021/jf4029199
  • Vanderkelen L, Van Herreweghe JM, Callewaert L, et al. Goose-type lysozyme inhibitor (PliG) enhances survival of Escherichia coli in goose egg albumen. Appl Environ Microbiol. 2011;77:4697–9. doi:10.1128/AEM.00427-11
  • Clarke CA, Scheurwater EM, Clarke AJ. The vertebrate lysozyme inhibitor Ivy functions to inhibit the activity of lytic transglycosylase. J Biol Chem. 2010;285:14843–7. doi:10.1074/jbc.C110.120931
  • Uehara T, Suefuji K, Valbuena N, et al. Recycling of the anhydro-N-acetylmuramic acid derived from cell wall murein involves a two-step conversion to N-acetylglucosamine-phosphate. J Bacteriol. 2005;187:3643–9. doi:10.1128/JB.187.11.3643-3649.2005
  • Tivendale KA, Logue CM, Kariyawasam S, et al. Avian-pathogenic Escherichia coli strains are similar to neonatal meningitis E. coli strains and are able to cause meningitis in the rat model of human disease. Infect Immun. 2010;78:3412–9. doi:10.1128/IAI.00347-10
  • Li G, Laturnus C, Ewers C, et al. Identification of genes required for avian Escherichia coli septicemia by signature-tagged mutagenesis. Infect Immun. 2005;73:2818–27. doi:10.1128/IAI.73.5.2818-2827.2005
  • Sambrook JF, Russell DW. Molecular cloning: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 2001.
  • Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. PNAS. 2000;97:6640–5. doi:10.1073/pnas.120163297
  • Cai W, Wannemuehler Y, Dell'anna G, et al. A novel two-component signaling system facilitates uropathogenic Escherichia coli's ability to exploit abundant host metabolites. PLoS Pathog. 2013;9:e1003428. doi:10.1371/journal.ppat.1003428
  • Tsai CM, Frasch CE. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem. 1982;119:115–9. doi:10.1016/0003-2697(82)90673-X
  • Deckers D, Vanlint D, Callewaert L, et al. Role of the lysozyme inhibitor Ivy in growth or survival of Escherichia coli and Pseudomonas aeruginosa bacteria in hen egg white and in human saliva and breast milk. Appl Environ Microbiol. 2008;74:4434–9. doi:10.1128/AEM.00589-08
  • Leyva A, Quintana A, Sanchez M, et al. Rapid and sensitive anthrone-sulfuric acid assay in microplate format to quantify carbohydrate in biopharmaceutical products: method development and validation. Biologicals. 2008;36:134–41. doi:10.1016/j.biologicals.2007.09.001
  • Morrison DC, Leive L. Fractions of lipopolysaccharide from Escherichia coli O111:B4 prepared by two extraction procedures. J Biol Chem. 1975;250:2911–19.
  • Caroff M, Tacken A, Szabo L. Detergent-accelerated hydrolysis of bacterial endotoxins and determination of the anomeric configuration of the glycosyl phosphate present in the “isolated lipid A” fragment of the Bordetella pertussis endotoxin. Carbohydr Res. 1988;175:273–82. doi:10.1016/0008-6215(88)84149-1
  • Lane MC, Alteri CJ, Smith SN, et al. Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. PNAS. 2007;104:16669–74. doi:10.1073/pnas.0607898104